CXCL12 and prostate cancer: Prostate cancer cells at primary sites released exosomes containing pyruvate kinase M2, which enhanced CXCL12 production by bone marrow stromal cells in a hypoxic inducible factor (HIF)-1α-dependent manner, giving rise to pre-metastatic niche [99].